Is HCMV a tumor promoter?
- PMID: 21036194
- PMCID: PMC3082728
- DOI: 10.1016/j.virusres.2010.10.026
Is HCMV a tumor promoter?
Abstract
Human cytomegalovirus (HCMV) is a beta-herpesvirus that causes persistent infection in humans and can cause severe disease in fetuses and immunocompromised individuals. Although HCMV is not currently causally implicated in human cancer, emerging evidence suggests that HCMV infection and expression may be specifically associated with human malignancies including malignant glioma, colon, and prostate cancer. In addition, multiple investigators have demonstrated that HCMV can dysregulate signaling pathways involved in initiation and promotion of malignancy, including tumor suppressor, mitogenic signaling, inflammatory, immune regulation, angiogenesis and invasion, and epigenetic mechanisms. This review highlights some of the recent evidence that HCMV might play a role in modulating the tumor microenvironment as well as in the initiation and promotion of tumor cells themselves.
Copyright © 2010 Elsevier B.V. All rights reserved.
Similar articles
-
Human cytomegalovirus and human herpesvirus 6 genes that transform and transactivate.Clin Microbiol Rev. 1999 Jul;12(3):367-82. doi: 10.1128/CMR.12.3.367. Clin Microbiol Rev. 1999. PMID: 10398670 Free PMC article. Review.
-
Human Cytomegalovirus UL111A and US27 Gene Products Enhance the CXCL12/CXCR4 Signaling Axis via Distinct Mechanisms.J Virol. 2018 Feb 12;92(5):e01981-17. doi: 10.1128/JVI.01981-17. Print 2018 Mar 1. J Virol. 2018. PMID: 29237840 Free PMC article.
-
Immune Landscape of CMV Infection in Cancer Patients: From "Canonical" Diseases Toward Virus-Elicited Oncomodulation.Front Immunol. 2021 Sep 8;12:730765. doi: 10.3389/fimmu.2021.730765. eCollection 2021. Front Immunol. 2021. PMID: 34566995 Free PMC article. Review.
-
The Human Cytomegalovirus Strain DB Activates Oncogenic Pathways in Mammary Epithelial Cells.EBioMedicine. 2018 Apr;30:167-183. doi: 10.1016/j.ebiom.2018.03.015. Epub 2018 Mar 28. EBioMedicine. 2018. PMID: 29628341 Free PMC article.
-
Is human cytomegalovirus a target in cancer therapy?Oncotarget. 2011 Dec;2(12):1329-38. doi: 10.18632/oncotarget.383. Oncotarget. 2011. PMID: 22246171 Free PMC article. Review.
Cited by
-
High-Risk Oncogenic Human Cytomegalovirus.Viruses. 2022 Nov 7;14(11):2462. doi: 10.3390/v14112462. Viruses. 2022. PMID: 36366560 Free PMC article. Review.
-
Selection of a highly invasive neuroblastoma cell population through long-term human cytomegalovirus infection.Oncogenesis. 2012 Apr 30;1(4):e10. doi: 10.1038/oncsis.2012.10. Oncogenesis. 2012. PMID: 23552602 Free PMC article.
-
The retinoblastoma tumor suppressor promotes efficient human cytomegalovirus lytic replication.J Virol. 2015 May;89(9):5012-21. doi: 10.1128/JVI.00175-15. Epub 2015 Feb 18. J Virol. 2015. PMID: 25694602 Free PMC article.
-
Increased HCMV seroprevalence in patients with hepatocellular carcinoma.Virol J. 2011 Oct 27;8:485. doi: 10.1186/1743-422X-8-485. Virol J. 2011. PMID: 22032643 Free PMC article.
-
Significant association of multiple human cytomegalovirus genomic Loci with glioblastoma multiforme samples.J Virol. 2012 Jan;86(2):854-64. doi: 10.1128/JVI.06097-11. Epub 2011 Nov 16. J Virol. 2012. PMID: 22090104 Free PMC article.
References
-
- Ahmad A, Wang Z, Kong D, Ali R, Ali S, Banerjee S, Sarkar FH. Platelet-derived growth factor-D contributes to aggressiveness of breast cancer cells by up-regulating Notch and NF-kappaB signaling pathways. Breast Cancer Res Treat - PubMed
-
- Albrecht T, Deng CZ, Abdel-Rahman SZ, Fons M, Cinciripini P, El-Zein RA. Differential mutagen sensitivity of peripheral blood lymphocytes from smokers and nonsmokers: effect of human cytomegalovirus infection. Environ Mol Mutagen. 2004;43(3):169–78. - PubMed
-
- Allart S, Martin H, Detraves C, Terrasson J, Caput D, Davrinche C. Human cytomegalovirus induces drug resistance and alteration of programmed cell death by accumulation of deltaN-p73alpha. J Biol Chem. 2002;277(32):29063–8. - PubMed
-
- Allavena P, Sica A, Garlanda C, Mantovani A. The Yin-Yang of tumor-associated macrophages in neoplastic progression and immune surveillance. Immunol Rev. 2008;222:155–61. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources